I also think the FDA approval is not a game changer (since the so called " Bronchitol business restructure" did not happen) for the share price, unless Chiesi can do a magical sale figure in US market. There is a chance, although remote, that the LOXL2 deal can be announced. But 2+ years already since Gary Philips bragging the drug has drawn huge interests from big pharams, I doubt this is going to happen at all.
Bone cancer is a new, cool and fancy story, which I guess will last a year or two for these guys enjoying the shareholders' money for their salary and bonus,
Show the deal and show the money Gary, or you are nothing but a liar.
PXS Price at posting:
9.4¢ Sentiment: Hold Disclosure: Held
